1 december 2011: Bron: Breast Cancer Res Treat. 2010 Jan;119(2):325-33. Epub 2009 Mar 5.

In deze dierstudie wordt PDT - photo dynamische therapie toegepast bij muizen die botuitzaaiingen hebben vanuit borstkanker. En blijkt de PDT  aanpak uitstekend te werken. Hier het abstract van de studie. Het volledige studierapport kunt u inzien bij Springerlink als u hier klikt

Breast Cancer Res Treat. 2010 Jan;119(2):325-33. Epub 2009 Mar 5.

Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).


Division of Orthopaedic Surgery, Sunnybrook Health Science Centre, Room E2-44, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada. makens@sri.utoronto.ca


Breast cancer is known to cause metastatic lesions in the bone, which can lead to skeletal-related events. Currently, radiation therapy and surgery are the treatment of choice, but the success rate varies and additional adjuncts are desirable. Photodynamic therapy (PDT) has been applied successfully as a non-radiative treatment for numerous cancers. Earlier work has shown that the athymic rat model is suitable to investigate the effect of PDT on bone metastasis and benzoporphyrin-derivative monoacid ring A (BPD-MA; verteporfin) has been shown to be a selective photosensitizer. The aim of this study was to define the therapeutic window of photosensitizer with regard to drug and light dose. Human breast carcinoma cells (MT-1)-stable transfected with the luciferase gene-were injected intra-cardiacally into athymic rats. At 14 days, the largest vertebral lesion by bioluminescence imaging was targeted for single treatment PDT. A drug escalating-de-escalating scheme was used (starting drug dose and light energy of 0.2 mg/kg and 50 J, respectively). Outcomes included 48 h post-treatment bioluminescence of remaining viable tumour, histomorphometric assessment of tumour burden, and neurologic evaluation. The region of effect by bioluminescence and histology increased with increasing drug dose and light energy. A safe and effective drug-light dose combination in this model appears to be 0.5 mg/kg BPD-MA and applied light energy of less than 50 J for the thoracic spine and 1.0 mg/kg and 75 J for the lumbar spine. For translation to clinical use, it is an advantage that BPD-MA (verteporfin), a second-generation photosensitizer, is already approved to treat age-related macular degeneration. Overall, PDT represents an exciting potential new minimally-invasive local, safe and effective therapy in the management of patients with spinal metastases.

[PubMed - indexed for MEDLINE]

Plaats een reactie ...

Reageer op "PDT - photo dynamische therapie werkt uitstekend bij weghalen van botuitzaaiingen in dierproeven"

Gerelateerde artikelen

Gerelateerde artikelen

PDT - photodynamische therapie >> PDT - Photo Dynamische Therapie >> PDT - photo dynamische therapie >> Borstkanker: PDT - Photodynamische >>